Introduction
strained by conformational and steric effects.
One of the most extensively studied proteins that SH3 domains have been identified in a variety of cellular contains both SH2 and SH3 domains is the Ras regulatory proteins, many of which function as components of signal protein, p120 RasGAP (Trahey et al., 1988) . The aminotransduction pathways (Cohen et al., 1995; Pawson, 1995) .
terminal region of RasGAP contains a single SH3 domain These include the large array of Src family kinases, flanked by two SH2 domains (Trahey et al., 1988) . The RasGAP, phospholipase C-γ (PLC-γ), p85 phosphatidylRasGAP SH2 domains have been found to associate with inositol-3 kinase, Stat and the adaptor proteins, Crk, Grb2 activated growth factor receptors and with a tyrosineand Nck. This conserved domain, which is~55 amino phosphorylated protein, p62, which is mitogen regulated acids in length, has been found to mediate a high-affinity Kaplan et al., 1990; Kazlauskas et al. , interaction between the SH3-containing protein and 1990; Margolis et al., 1990; Reedijk et al., 1990 ; Pronk specific proline-rich peptides which have been identified et al., 1992) . These are relatively low abundance protein in numerous proteins (Ren et al., 1993) . While the precise complexes, whereas the major cellular complex formed role of SH3 domains has not been elucidated, it appears with RasGAP is that with p190 RhoGAP, a Rho GTPase that the interactions promoted by these domains can direct regulatory protein (Moran et al., 1991; , such aspects of protein function as subcellular localization 1992a). In tyrosine kinase-transformed cells, nearly all of and cytoskeletal association (Bar-Sagi et al., 1993) , enzyme complex assembly (Sumimoto et al., 1994) and the RasGAP is associated with p190 in a cytoplasmic plex may serve to coordinate Ras-and Rho-mediated p190-B (Burbelo et al., 1995) , and with the RasGAP binding region of the PDGF receptor (Fantl et al., 1992) .
signaling pathways (Settleman et al., 1992a) . However, the biological consequences of RasGAP-p190 complex formation have not yet been determined. To gain insight domain, but only weakly with the individual SH2 domains. The isolated SH3 domain does not bind p190. Similar into the regulatory mechanism and function of this protein complex, we examined the structural requirements of the results with baculovirus-produced p190 have been reported recently (Bryant et al., 1995) . To map the binding site(s) on SH2-mediated RasGAP-p190 interaction. Surprisingly, this analysis revealed that the likely function of p190 in p190 that mediates the RasGAP interaction, we prepared carboxy-terminal truncation mutants of p190 in the Cos the RasGAP signaling complex is to promote a substantial conformational change in RasGAP that exposes the normexpression vector and tested their ability to bind the RasGAP SH2-SH3-SH2 domain following transfection. ally inaccessible target binding surface of the SH3 domain, thereby making it available for additional protein interThis analysis localized the RasGAP binding region to amino acids 1075-1142 of p190, which are located just actions.
upstream of the carboxy-terminal RhoGAP catalytic domain ( Figure 2A ).
Results
Inspection of this sequence revealed that it contains two closely spaced tyrosines (Y1087 and Y1105) within Mapping the RasGAP binding sites in p190 RhoGAP peptide sequences that have the same amino acids at positions ϩ3 (proline) and ϩ5 (aspartic acid) relative to To establish the structural requirements of the RasGAPp190 complex, we first developed an assay for a RasGAP the tyrosine ( Figure 2B ). Notably, this sequence motif (YxxPxD) is also conserved in the RasGAP SH2 binding SH2-dependent interaction with p190 in transfected Cos cells. GST fusion proteins containing all or part of site in the platelet-derived growth factor (PDGF) receptor (Fantl et al., 1992) and at analogous positions in a recently the amino-terminal SH2-SH3-SH2 domain of RasGAP ( Figure 1A and B) were immobilized on glutathionereported p190-related protein (p190-B), which also binds RasGAP (Burbelo et al., 1995) . To test the possibility that agarose beads and used as affinity reagents to capture p190 from lysates of Cos cells that had been transfected these sites mediate RasGAP binding, we prepared synthetic peptides (10mers) corresponding to the two putative with an amino-terminally epitope-tagged (HA) form of p190. Associated p190 was then detected by immunoRasGAP binding sites in p190 (amino acids 1083-1092 and amino acids 1102-1111). Each peptide was synthesized blotting with anti-HA antibodies. As shown ( Figure 1C ), p190 readily associates with the RasGAP SH2-SH3-SH2 either with or without phosphorylated tyrosine at the relevant position and then tested for the ability to block an interaction between the GST-SH2-SH3-SH2 fusion protein and p190 expressed in baculovirus-infected insect cells. The phosphorylated peptides (100 μM) are each able to block nearly all of the complex formation with p190, whereas the unphosphorylated peptides, even when added together at high concentration, are unable to affect the interaction ( Figure 3A ). Fifty percent inhibition of binding could be achieved with~10 μM phosphopeptides (not shown).
To confirm that a similar binding mechanism is used in the context of the full-length RasGAP, we performed the same peptide competition experiment using insect cell lysates expressing full-length RasGAP and p190. For this analysis, we took advantage of a previous observation that the RasGAP-p190 complex can be formed efficiently in vitro by mixing lysates of RasGAP and p190 baculovirus-infected insect cells (Foster et al., 1994) . In such cells, p190 contains readily detectable levels of tyrosine phosphorylation as revealed by anti-phosphotyrosine immunoblotting (not shown). As with the isolated SH2-containing region of RasGAP, the interaction of full-length RasGAP with p190 is completely blocked by the p190 phosphopeptides ( Figure 3B ). Notably, either of the two individual phosphopeptides can completely block complex formation, suggesting that both of the RasGAP SH2 domains are able to bind either of these two p190 regions. This was in fact confirmed by performing a similar peptide competition experiment with the isolated individual GST-SH2 fusion proteins (data not shown). It is possible, however, that only one of the two possible orientations of these proteins relative to each other is normally found in the cellular complex between full-length RasGAP and p190 due to additional conformational constraints.
To confirm the requirement for these p190 domains in the RasGAP-p190 complex, we constructed and expressed mutated forms of p190 in which small in-frame deletions structed and expressed a GST fusion protein, GST-GBD (GAP binding domain), that contains an 89 amino acid region of p190 comprising the two RasGAP binding sites, immunoprecipitated from cell lysates with anti-RasGAP antibodies. Bound proteins were detected by immunoand examined its ability to bind RasGAP ( Figure 4A ). The fusion protein was immobilized on beads and used blotting with RasGAP-and p190-specific antibodies. As shown in Figure 4B , GST-GBD (but not GST alone) to capture RasGAP from Src-transformed fibroblast lysates. In parallel, RasGAP and associated p190 were coefficiently binds RasGAP in whole cell lysates. Notably, whereas anti-RasGAP immunoprecipitates contain both RasGAP and p190, the GST-GBD complex contains only the monomeric, non-p190-complexed form of RasGAP. These results demonstrate that this small region of p190 is both necessary and sufficient for RasGAP interaction. In addition, the fact that p190 is not present in the GST-GBD complex indicates that all of the cellular interactions of p190 with RasGAP are mediated by this domain in p190.
Bacterially produced GST-GBD is not tyrosine phosphorylated, indicating that complex formation can be achieved in vitro in the absence of phosphorylation. A similar observation was made previously in the baculovirus system (Bryant et al., 1995) . Phosphorylation-independent binding is only seen at high protein concentrations, side of the tyrosine has also been reported (Bibbins et al., 1993) . In addition, the fact that SH2 binding by the synthetic p190 peptides requires tyrosine phosphorylation binding sites in p190 are the major sites of phosphorylation by tyrosine kinases in vivo, we examined the ability of suggests that the tandem SH2 binding sites in p190 form a structure that is highly conducive to RasGAP binding, several tyrosine kinases to promote phosphorylation of p190 tyrosines 1087 and 1105. p190 expression constructs but which cannot be mimicked even by the combination of the two synthetic p190 peptides.
were transfected into Cos cells together with activated forms of either Src, Blk or Abl tyrosine kinases, and tyrosine phosphorylation of p190 was examined by The RasGAP binding domain of p190 is the major site of tyrosine phosphorylation in vivo immunoprecipitation of transfected p190 followed by immunoblotting with anti-phosphotyrosine antibodies. As p190 has been reported to undergo tyrosine phosphorylation and association with RasGAP in cells expressing shown ( Figure 5A ), co-transfection of each of these kinases with p190 results in substantial tyrosine phosphorylation activated tyrosine kinases Moran et al., 1991) . To determine whether the identified RasGAP of p190. However, co-transfection of these kinases with p190 RhoGAP regulates the RasGAP SH3 domain a p190 mutant in which tyrosines 1087 and 1105 have For these studies, we made use of a monoclonal antibody (B4F8) that we had previously generated that specifically been substituted with phenylalanine (190-FF) did not give rise to a significant increase in p190 tyrosine phosphorylrecognizes the RasGAP SH3 domain. To confirm the antibody specificity, GST fusion proteins containing ation, suggesting that most of the tyrosine phosphorylation on p190 in vivo occurs on the two tyrosines in the RasGAP various regions of the amino-terminal portion of RasGAP were analyzed by immunoblotting with monoclonal antibinding domain. The fact that the basal level of p190 tyrosine phosphorylbody B4F8. As shown in Figure 6A , this antibody specifically recognizes an isolated 58 amino acid region ation seen in the absence of co-transfected kinase is reduced in the double tyrosine mutant (190-FF) also of RasGAP that comprises only the SH3 domain. We hypothesized that by titrating the amount of this antibody indicates that these are the major sites of p190 tyrosine phosphorylation by endogenous tyrosine kinases. For the in an immunoprecipitation of recombinant RasGAP, we could compare its ability to bind the RasGAP SH3 domain Src and Blk kinases, it appears that there is at least one additional site of p190 tyrosine phosphorylation, which is in the presence or absence of associated p190, and thereby measure accessibility of the SH3 domain. not seen with Abl. By re-probing this same immunoblot with anti-RasGAP antibodies, we were able to examine
To test this possibility, RasGAP-containing insect cell lysate was mixed with either a 20-fold excess of p190-the relationship between phosphorylation of tyrosines 1087 and 1105 of p190 and the ability to associate with RasGAP.
containing lysate or an equivalent amount of lysate prepared from uninfected cells, and the mixed lysates were As shown in Figure 5B , phosphorylation of tyrosines 1087 and 1105 is necessary for p190 to co-precipitate subjected to immunoprecipitation with a range of B4F8 antibody concentrations. Immunoprecipitated proteins endogenous RasGAP. Thus, these two tyrosines in the RasGAP binding domain of p190 appear to be the major were analyzed by immunoblotting with anti-RasGAP antibody to assess the efficiency of immunoprecipitation. As sites of phosphorylation by several tyrosine kinases in vivo. Moreover, it seems likely that an important role for shown ( Figure 6B ), in the presence of excess p190, RasGAP can be immunoprecipitated by the SH3-specific tyrosine phosphorylation of p190 by several different kinases is to regulate its association with RasGAP.
antibody with much greater efficiency than RasGAP in the absence of p190. Based on the antibody titration Since we had already observed that the RasGAP-p190-GBD interaction could be formed in vitro in the absence results, we estimate that in the presence of p190 the accessibility of the RasGAP SH3 domain is increased by of p190 tyrosine phosphorylation when using high concentrations of GST-GBD fusion protein, we wanted to confirm~100-fold. As a control, the same experiment was performed with an antibody that recognizes a carboxythat this interaction mimics the normal in vivo interaction of RasGAP and p190 that takes place when the proteins terminal region of RasGAP and, as expected, no difference in immunoprecipitation efficiency was observed in the are present at more physiologic concentrations. For this analysis, we prepared mammalian expression constructs presence or absence of p190 ( Figure 6C ). This result indicates that the conformational effects of p190 on from which the GST-GBD fusion protein and a double tyrosine mutant (GST-GBD-FF) could be expressed in RasGAP are confined to the SH3 domain. We next examined the ability of the isolated RasGAP transfected cells. Cos cells were transfected with these plasmids in the presence or absence of a co-transfected binding region of p190 to promote the same conformational change in RasGAP. For this experiment, insect cell lysate Abl expression vector, and cell lysates were incubated with glutathione-agarose to capture expressed GST-GBD containing RasGAP was incubated with either the purified GST-GBD fusion protein (RasGAP binding domain of and associated RasGAP. As shown ( Figure 5C ), both GST-GBD and the GST-GBD-FF mutant are expressed p190) or GST alone as a control. The samples were subjected to B4F8 immunoprecipitation as before. As efficiently in transfected cells, and GST-GBD (but not GST-GBD-FF) is tyrosine phosphorylated in the presence shown ( Figure 6D ), GST-GBD is able to promote a conformational change in RasGAP as efficiently as the of Abl. Significantly, the presence of Abl increases the binding of GST-GBD to RasGAP, whereas GST-GBDfull-length p190 protein (100-fold). This result indicates that the only region of p190 required to promote access FF binding to RasGAP is not detectable even in the presence of Abl. Thus, these results demonstrate that to the RasGAP SH3 domain is the region containing the tandem SH2 binding sites. We have also found that high despite the fact that at high protein concentration the phosphorylation requirement for binding can be bypassed concentrations of the RasGAP binding p190 phosphopeptides, even when mixed together, have no effect on in vitro, interaction of this binding region of p190 with RasGAP in vivo is regulated by phosphorylation of these the accessibility of the SH3 domain when incubated with RasGAP (data not shown). This suggests that simple two tyrosines in p190.
occupancy of the RasGAP SH2 domains is not sufficient to expose the SH3 domain, but rather, the two SH2 p190 promotes a conformational change in RasGAP that exposes the SH3 domain domains must be brought into a specific conformationa function that p190 apparently is able to serve due to its The juxtaposition of the two SH2 binding sites in p190 (13 amino acid separation) suggests that binding of RasGAP to closely spaced SH2 binding domains. This hypothesis was confirmed using the antibody titration strategy with p190 via both of the SH2 domains potentially could promote a substantial conformational change in RasGAP mutated forms of GST-GBD (GST-GBD-M1 and GST-GBD-M2) that contain 10 amino acid deletions that remove that might affect the SH3 domain that is situated between the two SH2 domains. Therefore, we examined the posthe individual RasGAP binding sites. As shown in Figure  6D , neither of these fusion proteins is able to affect the sibility that the role of p190 in the RasGAP complex is to regulate the accessibility of the RasGAP SH3 domain. accessibility of the SH3 domain when incubated with
RasGAP. This result indicates that it is the coordinated action of both RasGAP binding sites in p190 that results in exposure of the SH3 domain.
To demonstrate that regulation of the RasGAP SH3 domain by tyrosine-phosphorylated p190 occurs in vivo, we took advantage of the fact that in Src-transformed Rat-1 fibroblasts, there is abundant p190 tyrosine phosphorylation and RasGAP-p190 complex formation relative to the untransformed parental Rat-1 cells (Moran et al., 1991; Foster et al., 1994) . Titration of the SH3-specific antibody in RasGAP immunoprecipitations of cell lysates from these two lines (normalized for RasGAP levels) revealed that in the Src-transformed cells, accessibility of the RasGAP SH3 domain is increased by~20-fold relative to that seen in untransformed Rat-1 cells ( Figure 6E ). These in vivo observations are consistent with the in vitro results, and support a specific regulatory role for p190 in the conformational changes in the RasGAP SH3 domain. It is likely that the apparently reduced effect of p190 on SH3 accessibility in the in vivo assay as compared with the in vitro assays (20-fold versus 100-fold) reflects the fact that the untransformed Rat-1 cells still contain detectable amounts of tyrosine-phosphorylated p190 as well as some co-immunoprecipitable RasGAP-p190 complex (data not shown). Therefore, it is expected that a fraction of the RasGAP in the Rat-1 cells will also have an exposed SH3 domain. It is also possible that the conformational change in the SH3 domain that we observe is in fact an underestimate of the actual change, since it is expected that the B4F8 antibody has to compete for RasGAP SH3 binding with the real cellular targets of this domain.
We wanted next to verify that the interaction of the SH3-specific B4F8 antibody with RasGAP reflects an interaction similar to that which normally occurs between the RasGAP SH3 domain and its cellular target(s). One of the most highly conserved amino acids in SH3 domains is a tryptophan (W317 in RasGAP) that participates directly in the interaction between the SH3 domain and the proline-rich SH3 binding site, as revealed by structural and mutational studies of several SH3-containing proteins (Musacchio et al., 1992; Yu et al., 1992 Yu et al., , 1994 ; Kohda exposes the target binding surface of the SH3 domain. (A) Antiet al., 1993; Koyama et al., 1993; Mattingly et al., 1994;  RasGAP antibody B4F8, which was previously found to recognize the Guruprasad et al., 1995) . Moreover, the NMR solution amino-terminal region of RasGAP, was tested by immunoblotting for specificity for the SH3 domain. GST fusion proteins (10 ng) structure of the isolated RasGAP SH3 domain revealed containing each of the RasGAP SH2 domains or the isolated 58 amino that amino acid W317 is located in the apparent binding acid SH3 domain were analyzed by SDS-PAGE followed by surface and is spatially arranged in a manner similar to immunoblotting with the B4F8 monoclonal antibody. (B) RasGAPthat seen in PLC-γ, suggesting that this tryptophan residue containing insect cell lysate was incubated (~10 ng of RasGAP per lane) with a 10-fold excess of either p190-containing insect cell lysate participates in target binding (Yang et al., 1994) . Therefore, (ϩp190) or an equivalent amount of lysate from uninfected cells we used site-directed mutagenesis to change this trypto- (-p190) , and then subjected to immunoprecipitation with the indicated phan in RasGAP to lysine and then examined the ability amounts of B4F8 antibody (~25 μg/ml). Samples were then analyzed of the B4F8 antibody to recognize the mutated RasGAP.
by SDS-PAGE followed by immunoblotting with anti-RasGAP As shown ( Figure 7A ), a GST-SH3 fusion protein con- Figure 7B ). This result indicates associate with the RasGAP SH3 domain or with a RasGAP SH3-SH2 fusion, but not with GST alone, a GST-SH2 fusion protein or SH3-containing fusions of the Crk and Nck proteins ( Figure 7C ). In addition, the RasGAP SH3 mutant containing the tryptophan substitution is defective in its ability to bind the 14 kDa protein. Together with the previous observations, these results indicate that there is at least one specific cellular target of the RasGAP SH3 domain which exhibits SH3 binding properties very similar to those seen with the B4F8 antibody, and is likely, therefore, to be influenced by p190. Due to relatively low levels of the 14 kDa SH3 target, it was not possible to detect an association between this protein and the endogenous RasGAP protein by co-immunoprecipitation from Rat-src cells (not shown).
Discussion
We have investigated the structural basis for the RasGAPp190 protein complex. This analysis revealed that tandem SH2 binding sites in p190 RhoGAP mediate a high-affinity interaction with RasGAP upon tyrosine phosphorylation of p190. Moreover, we have found that the tyrosines in these two binding sites of p190 (Y1087 and Y1105) are the major substrates in vivo for both Abl and Src family tyrosine kinases, suggesting that an important role for p190 phosphorylation by these kinases is to promote the association of p190 with RasGAP. It has been demonstrated previously that p190 is a major substrate for tyrosine phosphorylation in cells that are oncogenically transformed by tyrosine kinases, suggesting that formation of the RasGAP-p190 complex may be a critical step in the transformation process Moran et al., 1991) . Notably, p190 is a prominent tyrosine-phosphorylated protein in human chronic myelogenous leukemia cells (Druker et al., 1992) .
Although the biological consequences of the RasGAPp190 interaction are unknown, we have shown that the SH2-dependent association of RasGAP with p190 results in a local conformational change in RasGAP that exposes the target binding surface of the SH3 domain. It is possible fusions containing the RasGAP SH3, the SH3-SH2 domain, the C-terminal SH2 domain or the SH3-containing Crk and Nck proteins, However, the fact that RasGAP and p190 exhibit catalytic as indicated. In addition, the lysine-substituted RasGAP SH3 domain activities for Ras and Rho GTPases, respectively, and that was tested in the SH3-SH2 fusion (GST-SH3*-SH2). Bound proteins p190 possesses its own GTPase activity (Foster et al., were analyzed by 15% SDS-PAGE followed by fluorography. The 1994), raises the possibility that the RasGAP-p190 comRasGAP SH3 binding protein is indicated as p14.
plex may be subject to additional levels of regulation or may have additional signaling properties. In fact, it has ability to bind RasGAP and is still able to recognize the mutated SH3 domain (data not shown). Therefore, it been reported that RasGAP catalytic activity is reduced 3-to 4-fold when complexed with p190 (Moran et al., 1991) . appears that the increased accessibility of the RasGAP SH3 domain by p190 is limited to the target binding
The isolated RasGAP SH2-SH3-SH2 domain (but not full-length RasGAP) has been found to be active in several surface of the SH3 domain.
biological assays when overexpressed. These include cytoskeletal reorganization (McGlade et al., 1993) , adhesion to Detection of a RasGAP SH3 binding protein To determine whether we could detect a specific interaction extracellular matrix (McGlade et al., 1993) , transcriptional activation (Medema and de Laat, 1992) , oncogenic transbetween the RasGAP SH3 domain and any cellular protein, we used the GST-SH3 fusion protein immobilized on formation (McGlade et al., 1993; Mattingly et al., 1994) , uncoupling of G-proteins from muscarinic receptors beads to capture putative SH3 binding proteins from lysates of metabolically radiolabeled fibroblasts. A single (Martin et al., 1992) and neuronal differentiation (Nakata and Watanabe, 1996) . Notably, we find that the SH3 reproducibly detected protein of~14 kDa was found to is transmitted via the RasGAP SH3 domain. The results described here suggest that such a signal may depend on the activation of p190 by tyrosine phosphorylation. Since Src family kinases are able to promote specific phosphorylation of the RasGAP binding site in p190, it appears that the RasGAP-p190 complex may be a point of convergence for Ras-and Src-mediated signaling pathways. This hypothesis is also supported by the observation that a myristylation-defective Src protein cooperates with the isolated SH2-SH3-SH2 domain of RasGAP to transform cultured fibroblasts to an oncogenic state (DeClue et al., 1993) .
Unlike most previously described SH2-mediated interactions, which are detected at cellular membranes or cytoskeletal structures, the RasGAP-p190 complex is predominantly cytoplasmic (Moran et al., 1991) . In addition, the complex is quite abundant relative to other reported SH2-mediated complexes, and nearly all of the cellular RasGAP is associated with p190 in Src-transformed cells (Moran et al., 1991) . Together, these observations raise the possibility that the RasGAP-p190 complex may function as a cytoplasmic 'sink' for some RasGAP SH3 binding protein, potentially neutralizing its activity by making it unavailable. Recently, a 68 kDa RNA binding protein has been identified as a specific interactor with the RasGAP SH3 domain in vitro (Parker et al., 1996) . Thus far, this is the only reported target of the RasGAP SH3 domain; however, the biological relevance of this interaction has not yet been established. Moreover, we have been unable to detect this protein complex in the Src-transformed Rat-1 cells described here. Thus, determining the precise role of the RasGAP SH3 domain for the biological function of RasGAP will probably have to await the identification of additional SH3 targets. The 14 kDa RasGAP SH3 binding protein identified in these studies is a strong candidate for a relevant interactor, since the interaction is specific for the SH3 domain of RasGAP and it requires the target binding surface of the SH3 Although the structural basis for several SH3-mediated protein interactions has now been established, the regulatory mechanism for such interactions has not been elucidated previously. The results described here indicate domain in this isolated region of RasGAP is fully accessible, and is unaffected by association with p190 (our that local conformational changes can play an important regulatory role in such interactions. This type of indirect unpublished observation). This result suggests that the apparently activated state of this isolated region of RasGAP regulatory mechanism for SH3 interactions potentially provides additional specificity to protein complex formamay be due to constitutive exposure of the SH3 domain by relief from conformational constraints that normally tion. That is, unlike many SH2-regulated interactions, which depend only on activation of a particular tyrosine occur in the context of the full-length protein, where it appears to be buried. Consistent with this hypothesis is kinase and the presence of a relevant substrate, it appears that the interaction between RasGAP and putative SH3 the finding that the biological activities of the isolated SH2-SH3-SH2 domain are mediated by the SH3 domain binding target proteins requires activation of a tyrosine kinase as well as the presence of both RasGAP and p190. (Duchesne et al., 1993; Mattingly et al., 1994) .
Although the precise nature of the effector signal from Since the expression of p190 is restricted to the nervous system during embryogenesis (M.Brouns and J.Settleman, the RasGAP SH3 domain has not been established in mammalian cells, a RasGAP SH3-mediated signal from unpublished observation), whereas RasGAP is widely expressed (Henkemeyer et al., 1995) , it is conceivable Ras to the cdc2 kinase appears to be required for Xenopus oocyte maturation (Pomerance et al., 1996) . This signal that the RasGAP SH3 domain is only 'activated' in a subset of cells that express both RasGAP and p190. is independent of MAP kinase activation, suggesting that there may be a distinct Ras-mediated effector signal that Our studies of the RasGAP-p190 complex suggest that domain that also appears to influence the properties of the orthovanadate (1 mM). Lysates were clarified by centrifugation at Src SH3 domain (Superti-Furga et al., 1993) . In addition, 13 000 g. For immunoprecipitation, lysates were incubated for 1 h at the SH3-mediated Grb2-Sos complex is influenced by the 4°C with either anti-RasGAP monoclonal antibody or anti-HA epitope kinase-dependent association of Shc with the Grb2 SH2 monoclonal antibody 12CA5 followed by a 1 h incubation with protein A-Sepharose. Samples were washed three times with a solution condomain in activated T cells (Ravichandran et al., 1995) .
taining 20 mM HEPES, pH 7.4, 150 mM NaCl, 1 mM EDTA and 0.1%
This might be explained by a SH2-dependent Shc interTriton X-100, and then resolved by SDS-PAGE (7.5% acrylamide).
action with Grb2 that promotes a conformational change Proteins were then electroblotted by semi-dry transfer at 10 V for 1 h that is conducive to the SH3-mediated Grb2-Sos interonto nitrocellulose. Filters were blocked with either 5% milk (for B4F8, action. Since several signaling proteins have now been 12CA5, GST and D2D6 antibodies) or 3% bovine serum albumin (for PY20) in TBST for 1 h and then incubated for 1 h in primary antibody.
identified that contain tandemly arranged SH2 and SH3
After six washes of 5 min each in TBST, filters were incubated for domains, it is possible that a similar conformational 30 min in horseradish peroxidase-conjugated secondary antibody (Biomechanism is used widely to regulate SH3-mediated Rad), washed again, and developed by enhanced chemiluminescence interactions.
(NEN) and autoradiography. The carboxy-terminal RasGAP antibody was kindly provided by Onyx Pharmaceuticals.
Materials and methods

GST fusion protein binding assays
GST fusion proteins were expressed in XA90 bacteria by 2 h of IPTG Plasmid construction and mutagenesis induction of log-phase cultures. Proteins were purified from lysed cells GST fusion constructs were prepared by PCR-directed subcloning of the on glutathione-agarose beads (Sigma) as previously described (Foster indicated regions of RasGAP or p190 into pGex plasmids (Pharmacia). et al., 1996) . Protein expression was confirmed by SDS-PAGE followed Inserts were confirmed by DNA sequencing. Sequences from the RasGAP by Coomassie Blue staining. For binding assays,~2 μg of GST fusion SH2-SH3-SH2 region were obtained from a human RasGAP cDNA protein immobilized on beads were incubated with cell lysate for 1 h at clone (kindly provided by F.McCormick). GST-GBD contains amino 4°C with gentle rocking. Beads were washed as for immunoprecipitation acids 1055-1143 of rat p190. GST-Crk and GST-Nck expression vectors and analyzed by immunoblotting as described above. were kindly provided by B.Mayer. To express p190 in transfected cells, an HA epitope was added to the 5Ј end of the rat p190 coding sequence Peptide competition studies (Settleman et al., 1992b) by PCR and the entire coding sequence was Four peptides were custom synthesized in milligram quantities and subcloned into the RcCMV expression plasmid (Invitrogen). The plasmid HPLC purified by Quality Controlled Biochemicals, Inc. Peptide P1 has is referred to as RcHA190. Tyrosine kinase expression constructs were the sequence DPSDYAEPMD (single letter code), and corresponds to kindly provided by Joan Brugge (Src), Shiv Pillai (Blk) and Rick Van p190 amino acids 1083-1092. Peptide P2 has the sequence ENIYSVPEtten (Abl). The mammalian expression vector form of GST-GBD was HDS, and corresponds to p190 amino acids 1102-1111. Peptides P1* prepared by subcloning into the vector PEBG, which expresses GST and P2* are identical in sequence to P1 and P2, respectively, but contain fusion proteins under the control of the EF-1α promoter. To generate phosphotyrosine at the tyrosine position. For competition studies with carboxy-terminal truncation mutants of p190 in the RcHA190 expression GST-RasGAP SH2-SH3-SH2 fusion protein, GST fusion protein construct, the Erase-a-base system (Promega) was used. The 3Ј ends of immobilized on beads (~2 μg) was pre-incubated for 30 min at 4°C with deletion mutants were confirmed by DNA sequencing and expression of the various peptides at the indicated concentrations and then inbubated truncated protein was confirmed by immunoblotting of lysates from for 1 h with baculovirus-produced p190 (~200 ng). For studies with fulltransfected Cos cells with the D2D6 anti-p190 monoclonal antibody.
length RasGAP, lysate from RasGAP baculovirus-infected insect cells For single amino acid substitution mutations in the p190 coding sequence was pre-incubated with the various peptides as above and then mixed and the tryptophan to lysine substitution of the RasGAP SH3 domain, with an equivalent amount of lysate from p190 baculovirus-infected the pSELECT (Promega) mutagenesis system was used according to insect cells. RasGAP and associated p190 were then immunoprecipitated the manufacturer's specifications. The region of p190 containing the with RasGAP antibody and analyzed by immunoblotting RasGAP and mutation(s) was sequenced to confirm that only the expected substitution p190 simultaneously. was introduced and the mutated fragment was then subcloned into the full-length p190 expression vector. To generate the M1, M2 and M3 deletion mutations in p190, an overlapping PCR strategy was used to generate specific in-frame deletions of the indicated peptide sequences,
